175 related articles for article (PubMed ID: 36513601)
1. Metabolomics analysis of urine from patients with alcohol-associated liver disease reveals dysregulated caffeine metabolism.
Xu R; He L; Vatsalya V; Ma X; Kim S; Mueller EG; Feng W; McClain CJ; Zhang X
Am J Physiol Gastrointest Liver Physiol; 2023 Feb; 324(2):G142-G154. PubMed ID: 36513601
[TBL] [Abstract][Full Text] [Related]
2. Altered urinary tryptophan metabolites in alcohol-associated liver disease.
Xu R; Vatsalya V; He L; Ma X; Feng W; McClain CJ; Zhang X
Alcohol Clin Exp Res (Hoboken); 2023 Sep; 47(9):1665-1676. PubMed ID: 37431708
[TBL] [Abstract][Full Text] [Related]
3. What's in Metabolomics for Alcoholic Liver Disease?
Suciu AM; Crisan DA; Procopet BD; Radu CI; Socaciu C; Tantau MV; Stefanescu HO; Grigorescu M
J Gastrointestin Liver Dis; 2018 Mar; 27(1):51-58. PubMed ID: 29557415
[TBL] [Abstract][Full Text] [Related]
4. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model.
Manna SK; Patterson AD; Yang Q; Krausz KW; Idle JR; Fornace AJ; Gonzalez FJ
J Proteome Res; 2011 Sep; 10(9):4120-33. PubMed ID: 21749142
[TBL] [Abstract][Full Text] [Related]
5. Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity.
Calzadilla N; Zilberstein N; Hanscom M; Al Rashdan HT; Chacra W; Gill RK; Alrefai WA
Dig Liver Dis; 2024 Jun; 56(6):923-931. PubMed ID: 37923598
[TBL] [Abstract][Full Text] [Related]
6. Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model.
Manna SK; Thompson MD; Gonzalez FJ
Adv Exp Med Biol; 2015; 815():217-38. PubMed ID: 25427910
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease.
Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Han SH; Yang YJ; Baik GH; Bang CS; Kim DJ; Suk KT
Hepatol Int; 2024 Apr; 18(2):486-499. PubMed ID: 37000389
[TBL] [Abstract][Full Text] [Related]
8. Urinary acrolein metabolite levels in severe acute alcoholic hepatitis patients.
Vatsalya V; Kong M; Gobejishvili L; Chen WY; Srivastava S; Barve S; McClain C; Joshi-Barve S
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G115-G122. PubMed ID: 30234998
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Analysis of Nucleosides/Bases in the Urine and Serum of Patients with Alcohol-Associated Liver Disease.
He L; Vatsalya V; Ma X; Klinge CM; Cave MC; Feng W; McClain CJ; Zhang X
Metabolites; 2022 Nov; 12(12):. PubMed ID: 36557225
[TBL] [Abstract][Full Text] [Related]
10. Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake.
Rybak ME; Sternberg MR; Pao CI; Ahluwalia N; Pfeiffer CM
J Nutr; 2015 Apr; 145(4):766-74. PubMed ID: 25833779
[TBL] [Abstract][Full Text] [Related]
11. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse.
Manna SK; Patterson AD; Yang Q; Krausz KW; Li H; Idle JR; Fornace AJ; Gonzalez FJ
J Proteome Res; 2010 Aug; 9(8):4176-88. PubMed ID: 20540569
[TBL] [Abstract][Full Text] [Related]
12. Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice.
Charkoftaki G; Tan WY; Berrios-Carcamo P; Orlicky DJ; Golla JP; Garcia-Milian R; Aalizadeh R; Thomaidis NS; Thompson DC; Vasiliou V
Chem Biol Interact; 2022 Jun; 360():109931. PubMed ID: 35429548
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver disease.
Mrdjen M; Huang E; Pathak V; Bellar A; Welch N; Dasarathy J; Streem D; McClain CJ; Mitchell M; Radaeva S; Barton B; Szabo G; Dasarathy S; Wang Z; Hazen SL; Brown JM; Nagy LE
Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37820283
[TBL] [Abstract][Full Text] [Related]
14. Acetylation phenotypes and biological variation in a French Caucasian population.
Pontes ZB; Vincent-Viry M; Gueguen R; Galteau MM; Siest G
Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):59-68. PubMed ID: 8467011
[TBL] [Abstract][Full Text] [Related]
15. Differential Metabolic Pathways and Metabolites in a C57BL/6J Mouse Model of Alcoholic Liver Disease.
Ma T; Li Y; Zhu Y; Jiang S; Cheng C; Peng Z; Xu L
Med Sci Monit; 2020 May; 26():e924602. PubMed ID: 32384076
[TBL] [Abstract][Full Text] [Related]
16. Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide.
Shah ND; Ventura-Cots M; Abraldes JG; Alboraie M; Alfadhli A; Argemi J; Badia-Aranda E; Arús-Soler E; Barritt AS; Bessone F; Biryukova M; Carrilho FJ; Fernández MC; Dorta Guiridi Z; El Kassas M; Eng-Kiong T; Queiroz Farias A; George J; Gui W; Thurairajah PH; Hsiang JC; Husić-Selimovic A; Isakov V; Karoney M; Kim W; Kluwe J; Kochhar R; Dhaka N; Costa PM; Nabeshima Pharm MA; Ono SK; Reis D; Rodil A; Domech CR; Sáez-Royuela F; Scheurich C; Siow W; Sivac-Burina N; Dos Santos Traquino ES; Some F; Spreckic S; Tan S; Vorobioff J; Wandera A; Wu P; Yacoub M; Yang L; Yu Y; Zahiragic N; Zhang C; Cortez-Pinto H; Bataller R
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2320-2329.e12. PubMed ID: 30708110
[TBL] [Abstract][Full Text] [Related]
17. High resolution metabolomics technology reveals widespread pathway changes of alcoholic liver disease.
Zhang A; Yan G; Zhou X; Wang Y; Han Y; Guan Y; Sun H; Wang X
Mol Biosyst; 2016 Jan; 12(1):262-73. PubMed ID: 26593868
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of bile acid profiles in diagnosing and staging of alcoholic liver disease.
Zhang G; Chen H; Ren W; Huang J
Scand J Clin Lab Invest; 2023 Feb; 83(1):8-17. PubMed ID: 36484775
[TBL] [Abstract][Full Text] [Related]
19. Comparative metabolic disposition of [1-Me14C]caffeine in rats, mice, and Chinese hamsters.
Arnaud MJ
Drug Metab Dispos; 1985; 13(4):471-8. PubMed ID: 2863113
[TBL] [Abstract][Full Text] [Related]
20. Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment.
Nyéki A; Biollaz J; Kesselring UW; Décosterd LA
J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):73-84. PubMed ID: 11393735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
